Recommended antiemetic regimens for HEC and AC-containing regimens... | Download Table
SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer | Breast Cancer ...
Dose-dense chemotherapy for breast cancer: what does the future hold? | Future Oncology
Cancers | Free Full-Text | Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine
Anthracycline-free or short-term regimen as adjuvant chemotherapy for operable breast cancer: A phase III randomized non-inferiority trial - The Lancet Regional Health – Western Pacific
National Surgical Adjuvant Breast and Bowel Project (NSABP)
Chemotherapy for Uterus Cancer
Update on systemic treatment for newly diagnosed inflammatory breast cancer - ScienceDirect
1607-Breast adjuvant AC (DOXOrubicin and CYCLOPHOSPHamide) dose dense followed by PACLitaxel dose de | eviQ
Effect of Number of Treatment Cycles of Adjuvant Chemotherapy on Clinical Outcomes | Research To Practice
Timing of AC chemotherapy cycles for breast cancer patients initiating... | Download Scientific Diagram
Optimising dose-dense regimens for early breast cancer | Cancer World Archive
Schema. T, Taxotere (docetaxel); AC, doxorubicin/cyclophosphamide. | Download Scientific Diagram
Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome | Nature Communications
4102-Breast adjuvant/neoadjuvant AC (DOXOrubicin and CYCLOPHOSPHamide) dose dense | eviQ
Chemotherapy protocol a for HR ALL patients | Download Table
JCM | Free Full-Text | Current Treatment Landscape for Early Triple-Negative Breast Cancer (TNBC)
Standardizing Chemotherapy Regimen Nomenclature: A Proposal and Evaluation of the HemOnc and National Cancer Institute Thesaurus Regimen Content | JCO Clinical Cancer Informatics
Protocol MCP841 chemotherapy regimen. | Download Table
Chemotherapy protocol definition form | Download Scientific Diagram
Optimising dose-dense regimens for early breast cancer | Cancer World Archive
Phase III trial of doxorubicin plus cyclophosphamide (AC), docetaxel, and alternating AC and docetaxel as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802) - Annals of Oncology
Dose Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel... | Download Table
